BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, Vos MB. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 2014;6:3187-3201. [PMID: 25111123 DOI: 10.3390/nu6083187] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Campos V, Despland C, Brandejsky V, Kreis R, Schneiter P, Chiolero A, Boesch C, Tappy L. Sugar- and artificially sweetened beverages and intrahepatic fat: A randomized controlled trial. Obesity (Silver Spring) 2015;23:2335-9. [PMID: 26727115 DOI: 10.1002/oby.21310] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
2 Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CAM, Patel MJ, Cruz Munos J, Krebs NF, Xanthakos SA, Johnson RK; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Hypertension. Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association. Circulation 2017;135:e1017-34. [PMID: 27550974 DOI: 10.1161/CIR.0000000000000439] [Cited by in Crossref: 189] [Cited by in F6Publishing: 110] [Article Influence: 31.5] [Reference Citation Analysis]
3 DiStefano JK, Shaibi GQ. The relationship between excessive dietary fructose consumption and paediatric fatty liver disease. Pediatr Obes. 2020;e12759. [PMID: 33305889 DOI: 10.1111/ijpo.12759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Della Corte C, Liccardo D, Ferrari F, Alisi A, Nobili V. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 2014;15:2501-11. [DOI: 10.1517/14656566.2014.960389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Conte L, Somacal S, Nichelle SM, Rampelotto C, Robalo SS, Roehrs M, Emanuelli T. Short-Term Bixin Supplementation of Healthy Subjects Decreases the Susceptibility of LDL to Cu2+-Induced Oxidation Ex Vivo. J Nutr Metab 2019;2019:9407069. [PMID: 30944740 DOI: 10.1155/2019/9407069] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Choo VL, Sievenpiper JL. The ecologic validity of fructose feeding trials: supraphysiological feeding of fructose in human trials requires careful consideration when drawing conclusions on cardiometabolic risk. Front Nutr 2015;2:12. [PMID: 25988140 DOI: 10.3389/fnut.2015.00012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Hsu CC, Ness E, Kowdley KV. Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease. Adv Nutr. 2017;8:253-265. [PMID: 28298270 DOI: 10.3945/an.116.013730] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
8 Darand M, Darabi Z, Yari Z, Hekmatdoost A. Fructose Consumption is Associated with Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study from Iran. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.88283] [Reference Citation Analysis]
9 Africa JA, Newton KP, Schwimmer JB. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. Dig Dis Sci. 2016;61:1375-1386. [PMID: 27041377 DOI: 10.1007/s10620-016-4126-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
10 Campos V, Despland C, Brandejsky V, Kreis R, Schneiter P, Boesch C, Tappy L. Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial. Nutrients 2017;9:E202. [PMID: 28264429 DOI: 10.3390/nu9030202] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
11 Cananzi M, Vajro P, Rela M, Dhawan A. NAFLD and Liver Transplantation in Children—Working Group Report From the ILTS Single Topic Conference on NAFLD. Transplantation 2019;103:68-70. [DOI: 10.1097/tp.0000000000002490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Vos MB, Goran MI. Sugar, Sugar . . . Not So Sweet for the Liver. Gastroenterology 2017;153:642-5. [PMID: 28757270 DOI: 10.1053/j.gastro.2017.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Rosqvist F, Rydell A, Iggman D. The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)-A Systematic Review and Meta-Analysis. Front Nutr 2020;7:613221. [PMID: 33392241 DOI: 10.3389/fnut.2020.613221] [Reference Citation Analysis]
14 Medeiros RF, Gaique TG, Bento-bernardes T, Kindlovits R, Gomes TMB, Motta NAV, Brito FC, Fernandes-santos C, Oliveira KJ, Nóbrega ACL. Arginine and aerobic training prevent endothelial and metabolic alterations in rats at high risk for the development of the metabolic syndrome. Br J Nutr 2017;118:1-10. [DOI: 10.1017/s0007114517001702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
15 Softic S, Cohen DE, Kahn CR. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Dig Dis Sci 2016;61:1282-93. [PMID: 26856717 DOI: 10.1007/s10620-016-4054-0] [Cited by in Crossref: 251] [Cited by in F6Publishing: 229] [Article Influence: 41.8] [Reference Citation Analysis]
16 Mirtschink P, Jang C, Arany Z, Krek W. Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur Heart J 2018;39:2497-505. [PMID: 29020416 DOI: 10.1093/eurheartj/ehx518] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
17 Choo VL, Viguiliouk E, Blanco Mejia S, Cozma AI, Khan TA, Ha V, Wolever TMS, Leiter LA, Vuksan V, Kendall CWC, de Souza RJ, Jenkins DJA, Sievenpiper JL. Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies. BMJ 2018;363:k4644. [PMID: 30463844 DOI: 10.1136/bmj.k4644] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 10.8] [Reference Citation Analysis]
18 Braun HA, Faasse SA, Vos MB. Advances in Pediatric Fatty Liver Disease: Pathogenesis, Diagnosis, and Treatment. Gastroenterol Clin North Am 2018;47:949-68. [PMID: 30337043 DOI: 10.1016/j.gtc.2018.07.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Jin R, Vos MB. Fructose and liver function--is this behind nonalcoholic liver disease? Curr Opin Clin Nutr Metab Care 2015;18:490-5. [PMID: 26203597 DOI: 10.1097/MCO.0000000000000203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Softic S, Gupta MK, Wang GX, Fujisaka S, O'Neill BT, Rao TN, Willoughby J, Harbison C, Fitzgerald K, Ilkayeva O, Newgard CB, Cohen DE, Kahn CR. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest 2017;127:4059-74. [PMID: 28972537 DOI: 10.1172/JCI94585] [Cited by in Crossref: 124] [Cited by in F6Publishing: 75] [Article Influence: 24.8] [Reference Citation Analysis]
21 Gugliucci A. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance. Med Hypotheses 2016;93:87-92. [PMID: 27372863 DOI: 10.1016/j.mehy.2016.05.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
22 Milic S, Mikolasevic I, Krznaric-Zrnic I, Stanic M, Poropat G, Stimac D, Vlahovic-Palcevski V, Orlic L. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. Drug Des Devel Ther 2015;9:4835-45. [PMID: 26316717 DOI: 10.2147/DDDT.S64877] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
23 Fattore E, Botta F, Bosetti C. Effect of fructose instead of glucose or sucrose on cardiometabolic markers: a systematic review and meta-analysis of isoenergetic intervention trials. Nutr Rev 2021;79:209-26. [PMID: 33029629 DOI: 10.1093/nutrit/nuaa077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zafar MI, Frese M, Mills KE. Chronic Fructose Substitution for Glucose or Sucrose in Food or Beverages and Metabolic Outcomes: An Updated Systematic Review and Meta-Analysis. Front Nutr 2021;8:647600. [PMID: 33996873 DOI: 10.3389/fnut.2021.647600] [Reference Citation Analysis]
25 Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol 2015; 7(3): 575-582 [PMID: 25848481 DOI: 10.4254/wjh.v7.i3.575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
26 Parry SA, Hodson L. Influence of dietary macronutrients on liver fat accumulation and metabolism. J Investig Med 2017;65:1102-15. [PMID: 28947639 DOI: 10.1136/jim-2017-000524] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
27 Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, Alazraki A, Durelle J, Knight-Scott J, Newton KP, Cleeton R, Knott C, Konomi J, Middleton MS, Travers C, Sirlin CB, Hernandez A, Sekkarie A, McCracken C, Vos MB. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial. JAMA 2019;321:256-65. [PMID: 30667502 DOI: 10.1001/jama.2018.20579] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 24.3] [Reference Citation Analysis]
28 Alberti G, Gana JC, Santos JL. Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. Nutrients 2020;12:E3531. [PMID: 33212947 DOI: 10.3390/nu12113531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Moore JB, Gunn PJ, Fielding BA. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients. 2014;6:5679-5703. [PMID: 25514388 DOI: 10.3390/nu6125679] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
30 Gibson PS, Lang S, Dhawan A, Fitzpatrick E, Blumfield ML, Truby H, Hart KH, Moore JB. Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr. 2017;65:141-149. [PMID: 28737568 DOI: 10.1097/mpg.0000000000001624] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
31 Hannah WN Jr, Harrison SA. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. Clin Liver Dis. 2016;20:339-350. [PMID: 27063273 DOI: 10.1016/j.cld.2015.10.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
32 Bonsembiante L, Targher G, Maffeis C. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? Eur J Clin Nutr 2021. [PMID: 34006994 DOI: 10.1038/s41430-021-00928-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Della Corte KW, Perrar I, Penczynski KJ, Schwingshackl L, Herder C, Buyken AE. Effect of Dietary Sugar Intake on Biomarkers of Subclinical Inflammation: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients 2018;10:E606. [PMID: 29757229 DOI: 10.3390/nu10050606] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
34 Mann JP, Goonetilleke R, Mckiernan P. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Arch Dis Child 2015;100:673-7. [DOI: 10.1136/archdischild-2014-307985] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
35 El Khoury D, Pauley RJ, Berseth CL. Dietary approaches to managing nonalcoholic fatty liver disease. Nurse Pract 2021;46:19-26. [PMID: 33399334 DOI: 10.1097/01.NPR.0000731560.23509.ff] [Reference Citation Analysis]
36 Pereira RM, Botezelli JD, da Cruz Rodrigues KC, Mekary RA, Cintra DE, Pauli JR, da Silva ASR, Ropelle ER, de Moura LP. Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients 2017;9:E405. [PMID: 28425939 DOI: 10.3390/nu9040405] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
37 Kohut T, Panganiban J. Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken) 2021;17:185-90. [PMID: 33868663 DOI: 10.1002/cld.1022] [Reference Citation Analysis]
38 George ES, Forsyth A, Itsiopoulos C, Nicoll AJ, Ryan M, Sood S, Roberts SK, Tierney AC. Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. Adv Nutr. 2018;9:30-40. [PMID: 29438460 DOI: 10.1093/advances/nmx007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
39 Yang M, Gong S, Ye SQ, Lyman B, Geng L, Chen P, Li DY. Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 2014;6:4691-705. [PMID: 25353664 DOI: 10.3390/nu6114691] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
40 Plaz Torres MC, Aghemo A, Lleo A, Bodini G, Furnari M, Marabotto E, Miele L, Giannini EG. Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. Nutrients 2019;11:E2971. [PMID: 31817398 DOI: 10.3390/nu11122971] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
41 Vos MB, Dimick-santos L, Mehta R, Omokaro SO, Taminiau J, Schabel E, Kleiner DE, Szitanyi P, Socha P, Schwimmer JB, Noviello S, Silberg DG, Torstenson R, Miller V, Lavine JE, Adda N, Baldyga W, Banerjee R, Behling C, Boulos S, Burgess G, Calboli D, Charles E, Christian R, Cohen-bacrie C, Cosma-roman D, Danzer C, Delaet I, Delegge M, Dimick-santos L, Diprospero N, Donohue K, Fischer L, Fitzpatrick E, Fried M, Hagerty D, Hale P, Hildick K, Hum D, Jamil K, Jiang L, Karpen S, Kelly M, Kleiner DE, Kohli R, Kordy K, Krieger N, Lavine J, Lee L, Lefebvre E, Lopez P, Lyons E, Malahias L, Megnien S, Mehta R, Mesenbrink P, Miller V, Minnick P, Murray C, Nghiem T, Nicholson N, Noviello S, Omokaro SO, Pang W, Percival L, Peres D, Powell M, Roman D, Root M, Sampson C, Sanyal A, Schabel E, Schwarz K, Schwimmer JB, Seyedkazemi S, Shapiro D, Shringarpure R, Silberg D, Smith E, Socha P, Squires R, Szitanyi P, Taminiau J, Torstenson R, Treem W, Vig P, Vos M, Yamashita M, Zemel M. Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease. Gastroenterology 2019;157:1448-1456.e1. [DOI: 10.1053/j.gastro.2019.08.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
42 Sangüesa G, Roglans N, Laguna JC, Alegret M. Liquid fructose and liver insulin signaling: Molecular mechanisms controlling hepatic steatosis. Molecular Nutrition: Carbohydrates. Elsevier; 2019. pp. 149-72. [DOI: 10.1016/b978-0-12-849886-6.00004-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Kaliora AC, Kalafati IP, Gioxari A, Diolintzi A, Kokkinos A, Dedoussis GV. A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. Eur J Nutr 2018;57:2227-35. [PMID: 28695325 DOI: 10.1007/s00394-017-1499-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
44 Mann JP, Tang GY, Nobili V, Armstrong MJ. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review. Clinical Gastroenterology and Hepatology 2019;17:1457-1476.e7. [DOI: 10.1016/j.cgh.2018.05.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
45 Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, Mouzaki M, Sathya P, Schwimmer JB, Sundaram SS, Xanthakos SA. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319-34. [PMID: 28107283 DOI: 10.1097/MPG.0000000000001482] [Cited by in Crossref: 306] [Cited by in F6Publishing: 133] [Article Influence: 76.5] [Reference Citation Analysis]
46 Ma J, Karlsen MC, Chung M, Jacques PF, Saltzman E, Smith CE, Fox CS, McKeown NM. Potential link between excess added sugar intake and ectopic fat: a systematic review of randomized controlled trials. Nutr Rev 2016;74:18-32. [PMID: 26518034 DOI: 10.1093/nutrit/nuv047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
47 Katsagoni CN, Papachristou E, Sidossis A, Sidossis L. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review. Nutrients 2020;12:E2864. [PMID: 32961669 DOI: 10.3390/nu12092864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
48 Ratziu V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis. Transplantation 2019;103:28-38. [PMID: 30300289 DOI: 10.1097/TP.0000000000002483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
49 Ferolla SM, Silva LC, Ferrari MLA, da Cunha AS, Martins FDS, Couto CA, Ferrari TCA. Dietary approach in the treatment of nonalcoholic fatty liver disease. World J Hepatol 2015; 7(24): 2522-2534 [PMID: 26523205 DOI: 10.4254/wjh.v7.i24.2522] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
50 Lombardi R, Iuculano F, Pallini G, Fargion S, Fracanzani AL. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease. Int J Mol Sci 2020;21:E8761. [PMID: 33228237 DOI: 10.3390/ijms21228761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Bosy-Westphal A, Braun W, Albrecht V, Müller MJ. Determinants of ectopic liver fat in metabolic disease. Eur J Clin Nutr 2019;73:209-14. [PMID: 30323174 DOI: 10.1038/s41430-018-0323-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
52 Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ, Berger FG. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol 2020;17:352-64. [PMID: 32086499 DOI: 10.1038/s41575-019-0253-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
53 Hernandez-Rodas MC, Valenzuela R, Videla LA. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2015;16:25168-98. [PMID: 26512643 DOI: 10.3390/ijms161025168] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 9.9] [Reference Citation Analysis]
54 Bujtor M. Can dietary intake protect against low-grade inflammation in children and adolescents? Brain Behav Immun Health 2021;18:100369. [PMID: 34825233 DOI: 10.1016/j.bbih.2021.100369] [Reference Citation Analysis]
55 Stachowska E, Ryterska K, Maciejewska D, Banaszczak M, Milkiewicz P, Milkiewicz M, Gutowska I, Ossowski P, Kaczorowska M, Jamioł-Milc D, Sabinicz A, Napierała M, Wądołowska L, Raszeja-Wyszomirska J. Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). Int J Mol Sci 2016;17:E1192. [PMID: 27455252 DOI: 10.3390/ijms17071192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
56 George ES, Kucianski T, Mayr HL, Moschonis G, Tierney AC, Itsiopoulos C. A Mediterranean Diet Model in Australia: Strategies for Translating the Traditional Mediterranean Diet into a Multicultural Setting. Nutrients 2018;10:E465. [PMID: 29642557 DOI: 10.3390/nu10040465] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
57 Bujtor M, Turner AI, Torres SJ, Esteban-Gonzalo L, Pariante CM, Borsini A. Associations of Dietary Intake on Biological Markers of Inflammation in Children and Adolescents: A Systematic Review. Nutrients 2021;13:356. [PMID: 33503979 DOI: 10.3390/nu13020356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
58 Merino B, Fernández-Díaz CM, Cózar-Castellano I, Perdomo G. Intestinal Fructose and Glucose Metabolism in Health and Disease. Nutrients 2019;12:E94. [PMID: 31905727 DOI: 10.3390/nu12010094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
59 Kang LL, Zhang DM, Ma CH, Zhang JH, Jia KK, Liu JH, Wang R, Kong LD. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation. Sci Rep 2016;6:27460. [PMID: 27270216 DOI: 10.1038/srep27460] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
60 Ragavendran V, Muthunatesan S, Santhanam V, Arsic B. Synthesis and characterization of cinnamylidene acetone – A study on tuning of band gap by vibrational spectroscopic tools. Journal of Molecular Structure 2019;1184:593-603. [DOI: 10.1016/j.molstruc.2019.02.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Della Corte KA, Penczynski K, Kuhnle G, Perrar I, Herder C, Roden M, Wudy SA, Remer T, Alexy U, Buyken AE. The Prospective Association of Dietary Sugar Intake in Adolescence With Risk Markers of Type 2 Diabetes in Young Adulthood. Front Nutr 2020;7:615684. [PMID: 33537338 DOI: 10.3389/fnut.2020.615684] [Reference Citation Analysis]
62 Allarakha S, Dixit K, Zaheer MS, Siddiqi SS, Moinuddin, Ali A. Levels of anti-fructose-modified HSA antibodies correlate with disease status in diabetic subjects. International Journal of Biological Macromolecules 2016;88:93-101. [DOI: 10.1016/j.ijbiomac.2016.03.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 DiNicolantonio JJ, Subramonian AM, O'Keefe JH. Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis. Open Heart 2017;4:e000631. [PMID: 29118995 DOI: 10.1136/openhrt-2017-000631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
64 Jin R, Willment A, Patel SS, Sun X, Song M, Mannery YO, Kosters A, McClain CJ, Vos MB. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. Int J Hepatol. 2014;2014:560620. [PMID: 25328713 DOI: 10.1155/2014/560620] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
65 Chiavaroli L, de Souza RJ, Ha V, Cozma AI, Mirrahimi A, Wang DD, Yu M, Carleton AJ, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ, Sievenpiper JL. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding Trials. J Am Heart Assoc 2015;4:e001700. [PMID: 26358358 DOI: 10.1161/JAHA.114.001700] [Cited by in Crossref: 62] [Cited by in F6Publishing: 30] [Article Influence: 8.9] [Reference Citation Analysis]
66 Kaliora AC, Kokkinos A, Diolintzi A, Stoupaki M, Gioxari A, Kanellos PT, Dedoussis GVZ, Vlachogiannakos J, Revenas C, Ladas SD, Karathanos VT. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention. Food Funct 2016;7:4533-44. [DOI: 10.1039/c6fo01040g] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]